You are here

Gene Therapy Market Industry Size, Share, Growth, Outlook, Segmentation, Comprehensive Analysis by 2029

Gene Therapy Market size is expected to grow from US$ 7.94 Bn. in 2022 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2023 to 2029. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2029.

Gene Therapy Market Overview

The research released by Maximize Market Research assists clients in thoroughly comprehending the competitive environment, which serves as a roadmap for strategic planning. The market overview for Gene Therapy Market contains in-depth information on the market's size, trade data, top players, and different market metrics, including life cycle, trends, etc.

Gene Therapy Market Report Scope and Research Methodology

The competitive environment for the Gene Therapy Market market include technological adoption, financial standing, portfolio, merger and acquisition, joint ventures, and strategic alliances. The market's drivers, constraints, opportunities, and challenges are all covered in-depth in the report. A bottom-up technique was utilised in the analysis to comprehend market estimations and growth rates for Gene Therapy Market.

To comprehend market penetration, pricing and demand analysis, and the competitive environment, regional analysis of the Gene Therapy Market market was carried out at the local, regional, and international levels. The study offers fundamental data on the Gene Therapy Market market, including stakeholders, investors, and new entrants, which is utilized to create marketing strategies and raise capital.

The market's data was collected using both primary and secondary data methods. In addition to press headlines, annual reports and financial reports, white papers, etc., secondary data collection techniques include surveys, questionnaires, and telephone interviews with market leaders and business owners. While PORTER is used to assess the level of industry competition in the Gene Therapy Market, SWOT analysis is used to pinpoint the market's risks and weaknesses.

Gene Therapy Market Regional Insights

North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa make up the bulk of the market's segmentation. The report's Regional Analysis aids in comprehending the Gene Therapy Market market industry in various nations. The research provides a thorough analysis of all the variables, including market size, growth rate, and regional import and export.

Request For Free Sample:

Gene Therapy Market Segmentation

Acute Lymphoblastic Leukemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. In 2022, the Spinal Muscular Atrophy (SMA) sector had the biggest market share (41%), and by 2029, it is anticipated that this dominance will persist. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease's phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA. Zolgensma is the opening speaker in this segment.

The market is divided into Lentivirus, AAV, Retrovirus & gamma Retrovirus, Modified Herpes Simplex Virus, Adenovirus, and Non-viral Plasmid Vector based on the type of vector used. The AAV segment is anticipated to expand quickly between 2022 and 2029, with a CAGR of 27.9%. In 2022, the AAV sector had the most market share (43%). There will be a huge demand for AAV in the next years because its application has grown dramatically in recent years across several therapeutic disciplines. Their established non-pathogenicity is one of the most important factors influencing their adoption. AAV viral vector-based gene therapy research and development is being conducted by a number of firms, including Dimension Therapeutics, AGTC, Spark Therapeutics, Sangamo Biosciences, Biogen, and AveXis.

1. Global Gene Therapy Market, by Indication (2023-2029)

• Acute Lymphoblastic Leukemia (ALL)
• Inherited Retinal Disease
• Large B-cell Lymphoma
• Melanoma (lesions)
• Beta-Thalassemia Major/SCD
• Head & Neck Squamous Cell Carcinoma
• Peripheral Arterial Disease
• Spinal Muscular Atrophy (SMA)
• Others

2. Global Gene Therapy Market, by Vector Type (2023-2029)

• Lentivirus
• Retrovirus & gamma Retrovirus
• Modified Herpes Simplex Virus
• Adenovirus
• Non-viral Plasmid Vector

3. Global Gene Therapy Market, by Delivery Method (2023-2029)

• In Vivo
• Ex Vivo

4. Global Gene Therapy Market, by Gene Type (2023-2029)

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide
• Deficiency
• Growth factors
• Receptors
• Others

Gene Therapy Market Key Players

2. Bayer
3. Oxford BioMedica plc
4. Dimension Therapeutics, Inc.
5. Bristol-Myers Squibb Company
7. Applied Genetic Technologies Corp
8. F. Hoffmann-La Roche Ltd.
9. Bluebird Bio, Inc.
10. Novartis AG
11. Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
12. UniQure N.V.
13. Shire Plc;
14. Cellectis S.A.
15. Sangamo Therapeutics, Inc.
16. Orchard Therapeutics
17. Gilead Lifesciences, Inc.
18. Benitec Biopharma Ltd.
19. Sibiono GeneTech Co., Ltd.
20. Shanghai Sunway Biotech Co., Ltd
21. Gensight Biologics S.A.
22. Transgene
23. Calimmune, Inc
24. Epeius Biotechnologies Corp
25. Astellas Pharma, Inc
26. American Gene Technologies
27. BioMarin Pharmaceuticals, Inc.
28. Human Stem Cell Institute
29. Spark Therapeutics LLC
30. GlaxoSmithKline
31. Voyager Therapeutics

Request For Free Sample:

Key questions answered in the Gene Therapy Market are:

What is Gene Therapy Market?
What was the Gene Therapy Market market size in 2022?
What is the growth rate of the Gene Therapy Market?
Which are the factors expected to drive the Gene Therapy Market market growth?
What are the different segments of the Gene Therapy Market?
What are the factors restraining the growth of the Gene Therapy Market?
What is the demand pattern of the Gene Therapy Market?
What major challenges could the Gene Therapy Market face in the future?
Key Offerings:

Past Market Size and Competitive Landscape (2018 to 2022)
Past Pricing and price curve by region (2018 to 2022)
Market Size, Share, Size & Forecast by different segment | 2023−2029
Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
Market Segmentation – A detailed analysis by segment with their sub-segments and Region
Competitive Landscape – Profiles of selected key players by region from a strategic perspective
Competitive landscape – Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER’s analysis
Value chain and supply chain analysis
Legal Aspects of Business by Region
Lucrative business opportunities with SWOT analysis
About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

Contact Maximize Market Research:

? 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
? +1 800 507 4489
? +91 9607365656